Structure-based virtual screening, in vitro and in vivo analyses identified kaempferol 3-gentiobioside as an FXR partial agonist protecting against cholestatic liver disease
- DOI
- 10.1016/j.bmc.2026.118842
- Published
- 2027-01
- Container
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2026.118842,
title = {Structure-based virtual screening, in vitro and in vivo analyses identified kaempferol 3-gentiobioside as an FXR partial agonist protecting against cholestatic liver disease},
author = {Zhenghu Ban and Cong Chen and Yutong Zhang and Jiaojiao Tu and Xudong Jiang and Xiangduan Tan},
year = {2027},
journal = {Bioorganic \& Medicinal Chemistry},
doi = {10.1016/j.bmc.2026.118842},
url = {https://doi.org/10.1016/j.bmc.2026.118842}
}RIS
TY - JOUR TI - Structure-based virtual screening, in vitro and in vivo analyses identified kaempferol 3-gentiobioside as an FXR partial agonist protecting against cholestatic liver disease AU - Zhenghu Ban AU - Cong Chen AU - Yutong Zhang AU - Jiaojiao Tu AU - Xudong Jiang AU - Xiangduan Tan PY - 2027 JO - Bioorganic & Medicinal Chemistry DO - 10.1016/j.bmc.2026.118842 UR - https://doi.org/10.1016/j.bmc.2026.118842 ER -
APA
Ban, Z., Chen, C., Zhang, Y., Tu, J., Jiang, X., & Tan, X. (2027). Structure-based virtual screening, in vitro and in vivo analyses identified kaempferol 3-gentiobioside as an FXR partial agonist protecting against cholestatic liver disease. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2026.118842
Source records
- crossref · retrieved 2026-11-10T12:24:50.450Z